Skip to main content

Table 2 Clinical indications for CRS and HIPEC

From: Feasibility and outcomes of cytoreductive surgery and HIPEC for peritoneal surface malignancies in low- and middle-income countries: a single-center experience of 232 cases

Clinical indication Number Percentage
Carcinoma of the ovary 131 56.5%
Pseudomyxoma peritonei 43 18.5%
Colorectal cancer 31 13.4%
Malignant mesothelioma 13 5.6%
Gastric carcinoma 6 2.6%
Endometrial stromal sarcoma 5 2.2%
Granulosa cell tumor 3 1.3%